Schizophrenic psychoses in the second half of life
Huber, G.; Gross, G.; Schüttler, R.
Die Medizinische Welt 28(4): 166-168
1977
ISSN/ISBN: 0025-8512 PMID: 840036 Document Number: 118743
Document emailed within 1 workday
Related Documents
Schmidt, P. 1980: Relation of pharmacotherapy, regulation of life situations and analytically-oriented psychotherapy in schizophrenic psychoses under the conditions of an ambulatory psychiatric practice Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 21(A): 27-29Vinar, O. 1980: Maintenance treatment in schizophrenic psychoses Ceskoslovenska Psychiatrie 76(3): 197-203
Kneutgen, J. 1977: Music therapy of schizophrenic psychoses Die Medizinische Welt 28(28): 1222-1224
Hunger, J. 1974: Electroencephalographic findings in schizophrenic psychoses Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 114(1): 135-146
Shakhmatova-Pavlova, I.V.; Gindilis, V.M.; Rokhlina, M.L.; Kozlova, I.A. 1980: Genotypic specificity of schizophrenic psychoses Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 80(5): 719-726
Verhoeven, W.M.; Westenberg, H.G.; Van Ree, J.M. 1984: Biological determinants of schizophrenic psychoses L'Encephale 10(2): 53-68
Fagiani, M.B. 1980: Schizophrenic psychoses in a pair of monochorionic twins Minerva Psichiatrica 21(3): 291-300
Hinterhuber, H.; Neumann, R. 1985: Depressive syndromes within the scope of schizophrenic psychoses Wiener Medizinische Wochenschrift 135(18): 435-441
Van Praag, H.M.; Verhoeven, W.M.; van Ree, J.M.; de Wied, D. 1982: The treatment of schizophrenic psychoses with gamma-type endorphins Biological Psychiatry 17(1): 83-98
Ballenger, J.C.; Post, R.M. 1984: Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses Psychopharmacology Bulletin 20(3): 572-584
Taussigová, D.; Prokopová, Z.; Bastecký, J.; Vinar, O. 1973: Experience with long-acting depot--neuroleptics in schizophrenic psychoses Activitas Nervosa Superior 15(2): 83-84
Svestka, J.; Náhunek, K.; Cesková, E.; Rysánek, R.; Balsíková, J. 1989: Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses Activitas Nervosa Superior 31(1): 32-34
Möller, H.J.; Scharl, W.; von Zerssen, D. 1984: Disorders of premorbid social adaptation as a predictor of the 5-year prognosis of schizophrenic psychoses Der Nervenarzt 55(7): 358-364
Haase, H.J. 1979: Ambulatory continuing care of mental patients with manic depressive and schizophrenic psychoses Zfa. Zeitschrift für Allgemeinmedizin 55(16): 963-971
Semenov, S.F.; Pashutova, E.K. 1976: Clinical features and problems in the differential diagnosis of schizophrenic psychoses developing after delivery Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 76(5): 741-747
Cesková, E.; Svestka, J.; Rysánek, R. 1993: Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses Ceskoslovenska Psychiatrie 89(1): 11-14
Hrdlicka, M.; Zedkova, I.; Blatny, M.; Urbanek, T. 2009: Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study Neuro Endocrinology Letters 30(2): 256-261
Svestka, J.; Náhunek, K. 1989: Therapeutic results in acute phases of manic depressive and schizophrenic psychoses as possible predictors of the prophylactic effect Activitas Nervosa Superior 31(1): 51-52
Lancon, C.; Auquier, P.; Launois, R.; Toumi, M.; Llorca, P.M.; Bebbington, P.; Lehman, A. 2000: Evaluation of the quality of life of schizophrenic patients: validation of the brief version of the Quality of Life Interview L'Encephale 26(4): 11-16
Khouzam, H.R.; Battista, M.A.; Emes, R.; Ahles, S. 2005: Psychoses in late life: evaluation and management of disorders seen in primary care Geriatrics 60(3): 26-33